1. Home
  2. AIHS vs NXL Comparison

AIHS vs NXL Comparison

Compare AIHS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.26

Market Cap

7.3M

Sector

Finance

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.43

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
NXL
Founded
2014
2010
Country
China
United States
Employees
N/A
7
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
8.3M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AIHS
NXL
Price
$1.26
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
76.5K
322.1K
Earning Date
02-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
14.63
N/A
EPS
N/A
N/A
Revenue
$3,389,072.00
N/A
Revenue This Year
N/A
$120.99
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.33
52 Week High
$8.26
$2.00

Technical Indicators

Market Signals
Indicator
AIHS
NXL
Relative Strength Index (RSI) 42.71 51.70
Support Level $1.10 $0.37
Resistance Level $1.35 $0.46
Average True Range (ATR) 0.15 0.03
MACD -0.02 0.01
Stochastic Oscillator 9.71 81.88

Price Performance

Historical Comparison
AIHS
NXL

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: